Adjuvant chemotherapy following chemoradiotherapy as primary treatment for locally advanced cervical cancer versus chemoradiotherapy alone (OUTBACK): an international, open-label, randomised, phase 3 trial-Reference-Cited by-同舟云学术

Adjuvant chemotherapy following chemoradiotherapy as primary treatment for locally advanced cervical cancer versus chemoradiotherapy alone (OUTBACK): an international, open-label, randomised, phase 3 trial

Published:2023-05 Issue:5 Volume:24 Page:468-482
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Mileshkin Linda R,Moore Kathleen N,Barnes Elizabeth H,Gebski Val,Narayan Kailash,King Madeleine T,Bradshaw Nathan,Lee Yeh Chen,Diamante Katrina,Fyles Anthony W,Small William,Gaffney David K,Khaw Pearly,Brooks Susan,Thompson J Spencer,Huh Warner K,Mathews Cara A,Buck Martin,Suder Aneta,Lad Thomas E,Barani Igor J,Holschneider Christine H,Van Dyk Sylvia,Quinn Michael,Rischin Danny,Monk Bradley J,Stockler Martin R

Publisher

Elsevier BV

Subject

Oncology

Reference30 articles.

1. Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world;Kamangar;J Clin Oncol,2006

2. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Sung;CA Cancer J Clin,2021

3. Invasive cervical cancer: a failure of screening;Spayne;Eur J Public Health,2008

4. Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma;Keys;N Engl J Med,1999

5. Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer;Morris;N Engl J Med,1999

Cited by 57 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacokinetics and pharmacodynamics of angiogenesis inhibitors used to treat cervical cancer: current and future;Expert Opinion on Drug Metabolism & Toxicology;2024-09-09

2. Pembrolizumab plus Radiochemotherapie bei lokal fortgeschrittenem Zervixkarzinom – die prospektive, randomisierte KEYNOTE-A18-Phase-3-Studie;Strahlentherapie und Onkologie;2024-09-04

3. The relationship between household income and prognosis of patients with cervical adenocarcinoma in the United States: A retrospective cohort study based on the SEER database;European Journal of Surgical Oncology;2024-09

4. PROshot: Immunotherapy for Cervical Cancer, Epidermal Growth Factor Receptor-Mutated Stage III Lung Cancer, Perioperative Chemotherapy for Esophageal Cancer, Salvage Postprostatectomy Radiation and Androgen Deprivation Therapy, and Immunotherapy for Head and Neck Cancer;Practical Radiation Oncology;2024-09

5. Pembrolizumab or placebo with chemoradiotherapy followed by pembrolizumab or placebo for newly diagnosed, high-risk, locally advanced cervical cancer (ENGOT-cx11/GOG-3047/KEYNOTE-A18): overall survival results from a randomised, double-blind, placebo-controlled, phase 3 trial;The Lancet;2024-09